drugset / Trial / NCT04356326

Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy

NCT04356326 ↗

Phase 3 Recruiting 500 enrolled Centre Hospitalier Intercommunal Creteil
RandomizedParallel-groupTriple-blindTreatment

Summary

A randomized clinical trial to assess the efficiency of acetylsalicylic acid (aspirin) 150 mg/day started before 20 weeks of gestation in the prevention on maternal and fœtal complications in pregnant women with chronic hypertension.

Timeline

Start
2021-02-15
Primary completion
2029-02-28
Completion
2030-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 150 mg —